European School of Medicinal Chemistry ESMEC
XXXVIII Advanced Course of Medicinal Chemistry and Seminar for PhD students

Urbino, Palazzo Battiferri, Via Saffi 42

July 1-5, 2018

The mission of the ESMEC is to provide participants, PhD students and junior researchers from both academia and industry, with the most recent advances in the field of medicinal and organic chemistry, pharmacology, molecular biology and analytical/ structural chemistry. This idea is aimed to reflect the current scenario of medicinal chemistry being a truly transdisciplinary approach, where the advances in knowledge are driven by the medicinal chemist’s ability to translate into new molecular concepts and into novel molecular entities the amount of information created by molecular medicine, pharmacology, molecular biology, systems biology.

For these reasons, the School is directed to participants at a graduated and post-graduated level, in chemistry but also in pharmacology or biology, who are keen to explore the interdisciplinary context of current cutting-edge research in medicinal chemistry.

To achieve these very ambitious goals, the School is organized into thematic sessions, each of them constructed around a series of lectures, followed by practical workshops.

This year the scientific programme includes the following topics:

Medicinal chemistry approaches in personalized medicines

Pelicci Pier Giuseppe, IEO, Milan (I)

Marinella Roberti, University of  Bologna (I)

Alan P. Kozikowski, StarWise Therapeutics LLC, Madison, WI (USA)

Emanuele Gabellieri, AC Immune SA, Lausanne (CH)

Continuous flow chemistry in drug discovery and development

Andreas Kirschning, Leibniz University of Hannover (D)

Antimo Gioiello, University of Perugia (I)

Giorgio Marini, CEM s.r.l., Cologno al Serio, BG (I)

Marcus Baumann, University College Dublin (IRL)


Reducing drug attrition rate: predictive PK and ligand residence time

Gerhard Ecker, University of Wien (A)

Gabriele Cruciani, University of Perugia (I)

Ismael Zamora, University of Pompeu Fabra, Barcelona (E) 

Valerio Mammoli, Aptuit, Verona (I)

Market watch: new drug approvals in 2017 and synthetic strategies

Tiziano Bandiera, Istituto Italiano di Tecnologia, Genova (I)


  • Deadline for Registration: June 15, 2018


Scientific Committee

Marco Macchia, University of Pisa (Director)
Stefania Butini, University of Siena
Andrea Cavalli, University of Bologna
Paolo Grieco, University of Naples
Antonio Macchiarulo, University of Perugia
Fabrizio Micheli, Aptuit s.r.l., Verona
Rui Moreira, University of Lisbon
Tracey Pirali, University of Piemonte Orientale
Gilberto Spadoni, University of Urbino Carlo Bo

Organizing Committee

Annalida Bedini
Lucia Bedini, Treasurer
Andrea Duranti
Simone Lucarini
Michele Mari

Organizing Office

Dipartimento di Scienze Biomolecolari
University of Urbino Carlo Bo
Piazza Rinascimento, 6
61029 Urbino (PU) ITALY
tel. +39 0722 304551 / +39 0722 303323
fax. +39 0722 303313